Soligenix Announces Pricing of $4.75 Million Public Offering [Yahoo! Finance]
Soligenix, Inc. (SNGX)
NASDAQ:AMEX Investor Relations:
soligenix.com/investors
Company Research
Source: Yahoo! Finance
focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced the pricing of its public offering of 11,875,000 shares of common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 11,875,000 shares of common stock at a combined public offering price of per share and accompanying warrant for aggregate gross proceeds of approximately $4.75 million , before deducting placement agent fees and other offering expenses. The warrants will have an exercise price of per share, will be exercisable immediately and will expire five years from the issuance date. The closing of the offering is expected to occur on or about April 22, 2024 , subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering to fund the Company's research and development and commercialization activities, and for general corporate and working capital purposes. A.G.P
Show less
Read more
Impact Snapshot
Event Time:
SNGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNGX alerts
High impacting Soligenix, Inc. news events
Weekly update
A roundup of the hottest topics
SNGX
News
- Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa [Yahoo! Finance]Yahoo! Finance
- Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South AfricaPR Newswire
- Soligenix Announces Pricing of $4.75 Million Public OfferingPR Newswire
- Why Is Penny Stock Soligenix Trading Higher On Monday? [Yahoo! Finance]Yahoo! Finance
- Soligenix stock soars 106% on FDA orphan drug status [Seeking Alpha]Seeking Alpha
SNGX
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEF
- 4/22/24 - Form 8-K
- SNGX's page on the SEC website